• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用禽流感病毒载体在人树突状细胞中高效表达肿瘤相关抗原MAGE-3。

Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector.

作者信息

Strobel I, Krumbholz M, Menke A, Hoffmann E, Dunbar P R, Bender A, Hobom G, Steinkasserer A, Schuler G, Grassmann R

机构信息

Department of Dermatology, University of Erlangen-Nürnberg, D-91052 Erlangen, Germany.

出版信息

Hum Gene Ther. 2000 Nov 1;11(16):2207-18. doi: 10.1089/104303400750035735.

DOI:10.1089/104303400750035735
PMID:11084678
Abstract

Dendritic cells (DCs) are the most potent inducers of immune reactions. Genetically modified DCs, which express tumor-associated antigens (TAA), can efficiently induce antitumor immunity and thus have a high potential as tools in cancer therapy. The gene delivery is most efficiently achieved by viral vectors. Here, we explored the capacity of influenza virus vectors to transduce TAA genes. These viruses abortively infect DCs without interfering with their antigen-presenting capacity. In contrast to other viruses used for DC transduction, influenza viruses can be efficiently controlled by antiviral pharmaceuticals, lack the ability to integrate into host chromosomes, and fail to establish persistent infections. Genes encoding a melanoma-derived TAA (MAGE-3), or the green fluorescence protein (GFP), were introduced into a high-expression avian influenza virus vector. Monocyte-derived mature DCs infected by these recombinants efficiently produced GFP or MAGE-3. More than 90% of the infected DCs can express a transduced gene. Importantly, these transduced DCs retained their characteristic phenotype and their potent allogeneic T cell stimulatory capacity, and were able to stimulate MAGE-3-specific CD8(+) cytotoxic T cells. Thus influenza virus vectors provide a highly efficient gene delivery system in order to transduce human DCs with TAA, which consequently stimulate TAA-specific T cells.

摘要

树突状细胞(DCs)是免疫反应最有效的诱导剂。表达肿瘤相关抗原(TAA)的基因修饰DCs能够有效诱导抗肿瘤免疫,因此作为癌症治疗工具具有很大潜力。基因传递通过病毒载体能最有效地实现。在此,我们探究了流感病毒载体转导TAA基因的能力。这些病毒能使DCs流产感染而不干扰其抗原呈递能力。与用于DC转导的其他病毒不同,流感病毒能被抗病毒药物有效控制,缺乏整合到宿主染色体的能力,且无法建立持续性感染。将编码黑色素瘤来源的TAA(MAGE - 3)或绿色荧光蛋白(GFP)的基因导入高表达禽流感病毒载体。被这些重组体感染的单核细胞衍生的成熟DCs能高效产生GFP或MAGE - 3。超过90%的感染DCs能表达转导基因。重要的是,这些转导的DCs保留了其特征性表型及其强大的同种异体T细胞刺激能力,并能够刺激MAGE - 3特异性CD8(+)细胞毒性T细胞。因此,流感病毒载体提供了一种高效的基因传递系统,以便用TAA转导人DCs,从而刺激TAA特异性T细胞。

相似文献

1
Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector.利用禽流感病毒载体在人树突状细胞中高效表达肿瘤相关抗原MAGE-3。
Hum Gene Ther. 2000 Nov 1;11(16):2207-18. doi: 10.1089/104303400750035735.
2
Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.慢病毒载体介导人抗原呈递细胞表达肿瘤相关表位。
Hum Gene Ther. 2004 Apr;15(4):393-404. doi: 10.1089/104303404322959542.
3
Immune characterization of clinical grade-dendritic cells generated from cancer patients and genetically modified by an ALVAC vector carrying MAGE minigenes.对由癌症患者产生并经携带MAGE小基因的ALVAC载体进行基因改造的临床级树突状细胞的免疫特征分析。
Cancer Gene Ther. 2005 Jun;12(6):552-9. doi: 10.1038/sj.cgt.7700804.
4
Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.使用基于1型人类免疫缺陷病毒的慢病毒载体将基因高效转移至人外周血单核细胞衍生的树突状细胞
Hum Gene Ther. 2000 Sep 1;11(13):1901-9. doi: 10.1089/10430340050129512.
5
Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells.逆转录病毒转导的人树突状细胞增强抗原特异性T细胞反应
Cell Immunol. 1999 Jul 10;195(1):10-7. doi: 10.1006/cimm.1999.1520.
6
Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system.基于HIV-1的慢病毒载体系统对人外周血单核细胞来源的树突状细胞和巨噬细胞的转导
Mol Ther. 2000 Feb;1(2):171-9. doi: 10.1006/mthe.2000.0027.
7
Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints.慢病毒介导的基因传递在人单核细胞衍生树突状细胞中的应用:符合临床要求的高效转导优化设计与操作流程
Cancer Gene Ther. 2002 Sep;9(9):715-24. doi: 10.1038/sj.cgt.7700500.
8
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.通过腺病毒介导的hCD40L基因与γ干扰素共转染,生成同时分泌白细胞介素-12并具有迁移能力的人树突状细胞。
J Immunother. 2009 Jun;32(5):524-38. doi: 10.1097/CJI.0b013e3181a28422.
9
Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.用编码 MAGE-A3 基因的重组慢病毒载体转导的树突状细胞诱导抗原特异性免疫应答。
J Cancer Res Clin Oncol. 2014 Feb;140(2):281-9. doi: 10.1007/s00432-013-1552-8. Epub 2013 Dec 10.
10
Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.通过mRNA电穿孔对树突状细胞进行单步抗原加载和激活,用于黑色素瘤患者的治疗性疫苗接种。
Clin Cancer Res. 2009 May 15;15(10):3366-75. doi: 10.1158/1078-0432.CCR-08-2982. Epub 2009 May 5.

引用本文的文献

1
Development and application of reverse genetic technology for the influenza virus.流感病毒反向遗传技术的发展与应用。
Virus Genes. 2021 Apr;57(2):151-163. doi: 10.1007/s11262-020-01822-9. Epub 2021 Feb 2.
2
Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.用于小鼠模型肿瘤治疗的重组λ噬菌体纳米生物颗粒。
Genet Vaccines Ther. 2010 May 12;8:3. doi: 10.1186/1479-0556-8-3.
3
Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine.一种神经氨酸酶缺陷型甲型流感病毒作为潜在基因递送载体和活疫苗的特性研究
J Virol. 2004 Mar;78(6):3083-8. doi: 10.1128/jvi.78.6.3083-3088.2004.
4
Nuclear localization of avian polyomavirus structural protein VP1 is a prerequisite for the formation of virus-like particles.禽多瘤病毒结构蛋白VP1的核定位是病毒样颗粒形成的先决条件。
J Virol. 2004 Jan;78(2):930-7. doi: 10.1128/jvi.78.2.930-937.2004.
5
Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene.用表达源自HER-2/neu原癌基因的细胞毒性T淋巴细胞(CTL)表位的减毒A型流感病毒感染的人树突状细胞激活肿瘤抗原特异性细胞毒性T淋巴细胞(CTL)。
J Virol. 2003 Jul;77(13):7411-24. doi: 10.1128/jvi.77.13.7411-7424.2003.
6
Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.通过电融合产生的树突状细胞与肿瘤细胞的杂交体在MHC I类和II类分子的背景下同时呈现来自多种人类肿瘤相关抗原的免疫显性表位。
J Immunol. 2003 May 15;170(10):5317-25. doi: 10.4049/jimmunol.170.10.5317.
7
Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles.复制缺陷型流感病毒样颗粒的免疫原性和保护效力
J Virol. 2002 Jan;76(2):767-73. doi: 10.1128/jvi.76.2.767-773.2002.